Mascoma Wealth Management LLC Viatris Inc Transaction History

Mascoma Wealth Management LLC

$400 Million
Q3 2024

A detailed history of Mascoma Wealth Management LLC transactions in Viatris Inc stock. As of the latest transaction made, Mascoma Wealth Management LLC holds 186 shares of VTRS stock, worth $2,302. This represents 0.0% of its overall portfolio holdings.

Number of Shares

186

Previous 186 -0.0%

Holding current value

$2,302

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$10.05 - $12.02 $331 - $396	33 Added 21.57%	186 $1,000
Q1 2024 May 02, 2024	SELL	$11.27 - $13.53 $552 - $662	-49 Reduced 24.26%	153 $1,000
Q4 2023 Jan 24, 2024	SELL	$8.77 - $10.85 $903 - $1,117	-103 Reduced 33.77%	202 $2,000
Q3 2023 Oct 13, 2023	SELL	$9.59 - $11.35 $383 - $454	-40 Reduced 11.59%	305 $3,000
Q2 2023 Aug 09, 2023	SELL	$9.02 - $10.29 $2,417 - $2,757	-268 Reduced 43.72%	345 $3,000
Q1 2023 May 01, 2023	SELL	$9.2 - $12.26 $561 - $747	-61 Reduced 9.05%	613 $5,000
Q4 2022 Jan 24, 2023	SELL	$8.72 - $11.56 $697 - $924	-80 Reduced 10.61%	674 $0
Q3 2022 Oct 18, 2022	SELL	$8.48 - $11.13 $186 - $244	-22 Reduced 2.84%	754 $6,000
Q2 2022 Jul 14, 2022	SELL	$9.95 - $12.27 $547 - $674	-55 Reduced 6.62%	776 $8,000
Q1 2022 Apr 25, 2022	SELL	$9.81 - $15.4 $647 - $1,016	-66 Reduced 7.36%	831 $9,000
Q4 2021 Jan 21, 2022	SELL	$12.09 - $14.68 $9,079 - $11,024	-751 Reduced 45.57%	897 $12,000
Q3 2021 Oct 06, 2021	BUY	$13.25 - $15.13 $21,836 - $24,934	1,648 New	1,648 $22,000
Q2 2021 Jul 06, 2021	SELL	$12.97 - $16.15 $44,746 - $55,717	-3,450 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$13.59 - $18.54 $46,885 - $63,963	3,450 New	3,450 $48,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mascoma Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mascoma Wealth Management LLC with notifications on news.

Account

Mascoma Wealth Management LLC Viatris Inc Transaction History